PeptidePedia The community reference

Talk:GLP-1 receptor agonist / Archive 1

Archived discussion·1 closed thread

This is an archive of past discussion on GLP-1 receptor agonist. Do not edit it. To revive a question, open a new section on the current talk page and link back to the thread here.

Half-life table: are the figures comparable?Resolved

The half-life column mixes terminal elimination half-lives from different study designs. Exenatide's 2.4 h is from a single-dose study; semaglutide's 165 h is from steady state. Putting them in one column implies a comparability that is not there. — HalfLifeHavel (talk) 09:12, 4 February 2026 (UTC)

Agreed in principle, but a reader wants the order of magnitude and the table gives it. I have added the mechanism column so the difference in kind is visible rather than only the difference in number. — MolarMassMaeve (talk) 13:40, 4 February 2026 (UTC)

That works. The mechanism column carries the caveat implicitly, and a reader who needs exact parameters will go to the individual articles. ✓ Done — HalfLifeHavel (talk) 08:55, 5 February 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.